Who owns ARRIVENT BIOPHARMA INC COM?
- Ticker: AVBP
- CUSIP Number: 04272n102
Tip: Access positions for across all investors
Analyze quarterly positions in Arrivent Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Arrivent Biopharma stock
Who bought or sold ARRIVENT BIOPHARMA INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hillhouse Capital Advisors | 4.5M | $83M | 14% | Jun 2024 |
|
| OrbiMed Advisors | 3.0M | $56M | 0% | Jun 2024 |
|
| FMR | 2.0M | $35M | 100% | Mar 2024 |
|
| Octagon Capital Advisors | 1.8M | $34M | -7% | Jun 2024 |
|
| Suvretta Capital Management | 1.7M | $32M | 10% | Jun 2024 |
|
| Sofinnova Ventures | 1.7M | $32M | 0% | Jun 2024 |
|
| Novo A/S | 1.5M | $28M | 39% | Jun 2024 |
|
| General Catalyst Group Management | 1.5M | $27M | 100% | Mar 2024 |
|
| Sc China Holding | 663k | $15M | 0% | Jun 2024 |
|
| BlackRock | 663k | $12M | 1% | Jun 2024 |
|
| Vanguard Group | 651k | $12M | 0% | Jun 2024 |
|
| Cormorant Asset Management | 515k | $9.6M | 0% | Jun 2024 |
|
| Perceptive Advisors | 415k | $7.7M | 0% | Jun 2024 |
|
| Geode Capital Management | 235k | $4.4M | 4% | Jun 2024 |
|
| State Street Corporation | 154k | $2.8M | 26% | Jun 2024 |
|
| Woodline Partners | 100k | $1.9M | 0% | Jun 2024 |
|
| AlphaCentric Advisors | 86k | $1.6M | 4% | Jun 2024 |
|
| Charles Schwab Investment Management | 80k | $1.5M | 3% | Jun 2024 |
|
| Northern Trust | 78k | $1.4M | 100% | Mar 2024 |
|
| Ghisallo Capital Management | 50k | $928k | 0% | Jun 2024 |
|
| Morgan Stanley | 41k | $768k | 96% | Jun 2024 |
|
| Hidden Lake Asset Management | 37k | $689k | 100% | Jun 2024 |
|
| Bank of New York Mellon | 30k | $554k | 31% | Jun 2024 |
|
| UBS O'Connor | 26k | $468k | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 25k | $447k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 18k | $326k | 36% | Jun 2024 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $307k | 256% | Jun 2024 |
|
| Jane Street | 15k | $284k | -59% | Jun 2024 |
|
| Rhumbline Advisers | 13k | $236k | 30% | Jun 2024 |
|
| Millennium Management | 12k | $225k | -94% | Jun 2024 |
|
| UBS Group | 9.9k | $177k | 100% | Mar 2024 |
|
| Bank of America Corporation | 6.3k | $117k | 179% | Jun 2024 |
|
| MetLife Investment Advisors | 6.1k | $113k | 100% | Jun 2024 |
|
| Mirae Asset Global Etfs Holdings | 4.9k | $91k | 100% | Jun 2024 |
|
| Jpmorgan Chase & Co | 4.4k | $82k | -65% | Jun 2024 |
|
| Wells Fargo & Company | 3.6k | $67k | 12% | Jun 2024 |
|
| Barclays | 3.4k | $63k | -76% | Jun 2024 |
|
| New York State Common Retirement Fund | 2.9k | $53k | 100% | Jun 2024 |
|
| Citigroup | 2.2k | $40k | 24% | Jun 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.7k | $32k | 0% | Jun 2024 |
|
| Tower Research Capital | 1.5k | $28k | 147% | Jun 2024 |
|
| Summit Investment Advisors | 981.00 | $18k | 0% | Jun 2024 |
|
| Royal Bank of Canada | 927.00 | $0 | 151% | Jun 2024 |
|
| Legal & General Group | 896.00 | $16k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 711.00 | $13k | -28% | Jun 2024 |
|
| Amalgamated Bank | 540.00 | $10k | 0% | Jun 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 390.00 | $7.2k | 100% | Jun 2024 |
|
| SRS Capital Advisors | 119.00 | $2.2k | 100% | Jun 2024 |
|
| CWM | 58.00 | $1.0k | 100% | Jun 2024 |
|
| NISA Investment Advisors | 27.00 | $501.001200 | 100% | Jun 2024 |
|
| GAMMA Investing | 10.00 | $186.000000 | 100% | Jun 2024 |
|
| Rothschild Investment | 5.00 | $93.000000 | 100% | Jun 2024 |
|
Who sold out of Arrivent Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Altitude Crest Partners | Mar 2024 | 556k | $9.9M |
| Citadel Advisors | Mar 2024 | 287k | $5.1M |
| Farallon Capital Management | Mar 2024 | 152k | $2.7M |
| MYDA Advisors | Mar 2024 | 30k | $536k |
| Point72 Asset Management | Mar 2024 | 29k | $516k |
| Blackstone Group | Mar 2024 | 25k | $447k |
| Point72 | Mar 2024 | 22k | $391k |
| American International | Mar 2024 | 4.8k | $87k |
| Cubist Systematic Strategies | Mar 2024 | 4.4k | $78k |
| Metropolitan Life Insurance Company | Mar 2024 | 567.00 | $10k |